Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R Slingerland
Intrapleural Administration of Interleukin 2 in Pleural Mesothelioma: A Phase I-Ii Study
British Journal of Cancer
Cancer Research
Oncology
Related publications
Phase II Study of Cediranib in Patients With Malignant Pleural Mesothelioma: SWOG S0509
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Brief Report: A Phase II Study of Sunitinib in Malignant Pleural Mesothelioma. The NCIC Clinical Trials Group
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Novel Therapies in Phase II and III Trials for Malignant Pleural Mesothelioma
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Phase II Study of Belinostat (PXD101), a Histone Deacetylase Inhibitor, for Second Line Therapy of Advanced Malignant Pleural Mesothelioma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
A Study of GATA-3 in Malignant Pleural Mesothelioma
Pathology
Forensic Medicine
Pathology
Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) as Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
P1.09-011 LUME-Meso Phase II/III Study: Nintedanib + Pemetrexed/Cisplatin in Chemo-Naïve Patients With Malignant Pleural Mesothelioma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
OA08.01 Long-Term Efficacy and Safety of Nivolumab in Second- Or Third-Line Japanese Malignant Pleural Mesothelioma Patients (Phase II: MERIT Study)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Malignant Pleural Mesothelioma
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
